Oxo[5,10,15,20-tetra(4-pyridyl)porphyrinato]titanium(IV) [Determination of Glucose in Serum and Urine]>90.0%(HPLC)100mg

2-Cyano-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(T)200mg

N-(4-AMINOPHENYL)ACRYLAMIDE, 95.0%, 1g

4-Nitrobenzenethiol>95.0%(GC)(T)5g

9,10-Dibutoxyanthracene, 95.0%, 5g

1-isopropyl-3-azetidinol, 95.0%, 1g

4-(cis-4-Hydroxycyclohexyl)phenol>97.0%(GC)200mg

4,4'-Diphenyl-2,2'-bipyridine, 97%, 500mg

METHYL 4-BROMO-2-CYANOBENZOATE, 95.0%, 1g

5-Bromo-2-hydroxy-4-methoxybenzaldehyde, 95.0%, 250mg

4-(3-Bromophenyl)butan-1-amine, 98%, 250mg

2-Bromo-5-(trifluoromethyl)-1,3,4-thiadiazole, 95.0%, 1g

(S)-6-Bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, 98%, 500mg